Pink Sheet Podcast: State Of Generic Industry, US FDA In Second Trump Term, Foreign Inspections

 
• By Derrick Gingery, Bowman Cox, and Nielsen Hobbs

Pink Sheet reporter and editors discuss the issues and concerns raised during a major generic industry conference, former Commissioner Gottlieb’s views on what a second Trump term would mean for FDA, and congressional hearings on foreign facility inspections and drug shortages.

Pink Sheet podcast
How will the FDA regain control of its inspection backlog? • Source: Citeline/Shutterstock

More from Generics

More from Biosimilars & Generics